Hrt Financial LP Pacific Biosciences Of California, Inc. Transaction History

Hrt Financial LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$8.23 - $13.93 $900,979 - $1.52 Million	109,475 Added 442.99%	134,188 $1.12 Million
Q2 2023 Aug 11, 2023	BUY	$9.97 - $14.05 $246,388 - $347,217	24,713 New	24,713 $328,000
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $593,705 - $1.29 Million	151,070 New	151,070 $876,000
Q2 2022 Aug 12, 2022	SELL	$4.02 - $10.43 $522,398 - $1.36 Million	-129,950 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $1.1 Million - $2.72 Million	129,950 New	129,950 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $789,679 - $1.23 Million	-41,001 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $1.02 Million - $1.44 Million	41,001 New	41,001 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $2.53 Million - $6.85 Million	-240,493 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.61 - $9.87 $868,179 - $2.37 Million	240,493 New	240,493 $2.37 Million
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $144,903 - $181,374	-24,477 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$6.8 - $7.4 $166,443 - $181,129	24,477 New	24,477 $176,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.